Location: Multi-centers in the US

Purpose: This study will test the safety and efficacy of an investigational medication in the treatment of patients with MS suffering from pseudobulbar affect (a condition characterized by frequent episodes of uncontrollable laughing and crying that are out of proportion with the underlying emotion; also called excessive emotionalism or emotional lability).

Eligibility: Women and men who are 18 to 68 years of age with a confirmed diagnosis of MS and who have pseudobulbar affect. A number of inclusion and exclusion criteria will determine your eligibility.

Procedures: Study-related tests including physical exam, EKG, and clinical labs are provided at no charge.

Benefit: May result in a new treatment for pseudobulbar affect in patients with MS.

For Information: Contact the National Multiple Sclerosis Society via their Web site at www.nationalmssociety.org or via telephone at 800-FIGHT MS (344-4867). For interested participants living within a 50-mile radius of Phoenix, Arizona, contact Louis DiCave or Colleen Sweeney at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center by phone at 602-406-7711.

This entry was posted on Monday, July 11th, 2005 at 9:52 pm and is filed under All Articles, MS Study Enrollments. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.